Anavex reports net loss for fiscal year 2015 $12.1M
Anavex had cash and cash equivalents of $15.3 million as of September 30, 2015, compared with $7.3 million as at…
Pharmaceuticals, Biotechnology and Life Sciences
Anavex had cash and cash equivalents of $15.3 million as of September 30, 2015, compared with $7.3 million as at…
Suven Life Sciences Ltd (SUVEN) has got the grant of one product patent from Europe and one product patent from Macau corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030 and 2029.
Nectar Lifesciences appoints Additional Independet Director
Valeant Pharmaceuticals International Inc Chief Executive J. Michael Pearson has been moved to another hospital where he is being treated for a severe case of pneumonia
Hikma Board has appointed Dr. Jochen Gann as BI’s first nominated director.
Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona
Indian pharmaceutical company Parabolic Drugs Limited has made certain changes to its board of directors. Namely, the company announced on…
AstraZeneca has completed its agreement with Perrigo Company plc for the divestment of US rights to Entocort.
Eli Lilly and Company has elected Juan R. Luciano as a new member of its board, effective February 1, 2016.
Johnson & Johnson Monday announced the formation of Verb Surgical Inc., an independent surgical solutions company, in collaboration with Verily Life Sciences…